Bionomics ( (BNOX) ) has issued an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Neuphoria Therapeutics Inc. has completed its redomiciliation, transferring governance from Bionomics’ organizational documents to Neuphoria’s new Certificate of Incorporation and bylaws. This strategic move positions Neuphoria as the successor issuer to Bionomics, with its shares now registered under the Exchange Act, which may influence its governance structure and shareholder rights.
More about Bionomics
YTD Price Performance: -83.65%
Average Trading Volume: 9,738,552
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.72M
Find detailed analytics on BNOX stock on TipRanks’ Stock Analysis page.